Some source checks need review. The dated references remain below. Confirm current guidance with the original source and your care team. Current policy statements are withheld where their checks have expired.
Joint pain has more than one explanation
Persistent joint pain or stiffness is a reason to discuss the pattern and activity limits with a clinician. Symptoms alone do not establish osteoarthritis or identify one damaged tissue.
Osteoarthritis can affect several structures in a joint and its impact varies. A supplement or peptide label does not tell you which condition you have or whether the product is suitable for it.
What a cartilage claim needs to show
Cartilage and the knee meniscus are structures within a joint; a claim about repairing them is different from a claim about pain. Check whether a study actually measured structure, symptoms, function or another outcome.
Do not translate a symptom questionnaire into cartilage regrowth. A finding in an animal, laboratory model or a different preparation also needs a clear boundary before it is used for a finished product.
Read the outcome before the headline
Ask what changed, how it was measured, what it was compared with and whether the result matters for the claim. The same word recovery can refer to very different outcomes.
A retrospective report of knee-pain improvement cannot separate all the reasons symptoms may have changed. It is not equivalent to a controlled demonstration that a product repaired cartilage.
Discuss function and practical care
An osteoarthritis care discussion may include activity, rehabilitation and other treatment options according to the person and their symptoms. The aim can include comfort, function and quality of life. Unexplained or inflammatory symptoms need the appropriate assessment first.
Bring the tasks that matter to you, current medicines and any product claim you have encountered. Ask how progress and side effects will be reviewed, rather than choosing from an undifferentiated list of repair products.
A product should match the question
This source check needs review. Confirm current guidance, sport rules and the exact product route with the original source before relying on a dated summary. This dated summary provides background on the comparison.
Dated source summary
Separate an oral nutritional product from a prescribed drug, an injection or a procedure. The exact formula, route and proposed use matter. Evidence for a specific preparation or population does not automatically support another brand.
Current compounding-policy developments do not establish that a product regenerates joint tissue. Check status and benefit evidence separately.
What changes the discussion?
Older age does not make every joint symptom the same condition. Recent injury, surgery, systemic symptoms, medicines and other health conditions can change what assessment is needed. Severe or worsening symptoms should not wait on a supplement trial.
Pregnancy and adolescent symptoms also need their own care context; a general adult product study does not settle those questions.
Bring a specific goal to the appointment
Describe whether the problem is pain, stiffness, instability or a task you can no longer do. Ask which diagnosis and outcome the proposed plan addresses. Then evaluate any product against that same question.
Where to go next
Sources and dates
The source date describes the original material; the review date records our check. A dated source summary is not continuous monitoring, product testing or confirmation of current purchase terms.
- [1]NIAMS: osteoarthritis · Source date: Source date not stated · Reviewed
Joint tissues, symptoms and variable functional impact.
- [2]NIAMS: osteoarthritis diagnosis and treatment · Source date: Source date not stated · Reviewed
Diagnosis and individualized symptom/function care, not cartilage-regrowth proof.
- [3]Jerger and colleagues: collagen plus resistance training · Source date: 2022 · Reviewed
Healthy male training study: tendon size and muscle thickness differed; strength and stiffness did not differ between groups. Not injured-patient healing.
- [4]Lee and colleagues: retrospective BPC-157 knee-pain report · Source date: 2021 · Reviewed
Retrospective intra-articular knee-pain observations, not proof of tendon repair or another finished product/route.
- [5]NIH ODS: dietary supplements, what you need to know · Source date: Source date is shown on the original page · Reviewed
Labels, quality, interactions, special situations and the limits of supplement oversight.
- [6]Praet and colleagues: collagen with Achilles rehabilitation · Source date: January 2, 2019 · Reviewed
Small crossover pilot of a specific collagen preparation with a calf-exercise program; symptoms/function, not all-brand injury repair.
- [7]HHS: interim peptide compounding policy and appendices · Source date: October 2026 policy document · Reviewed
Conditional enforcement-discretion context for specified 503A products, identities and routes; not marketing approval or recovery efficacy.
- [8]Federal Register: HHS peptide-policy notice · Source date: October 30, 2026 · Reviewed
Notice calls the policy draft/interim and nonbinding; current policy must be checked separately from a specific offer.
- [9]NIAMS: sports injury diagnosis and care · Source date: Source date not stated · Reviewed
Injury assessment, severity, rehabilitation and return decisions; no personal protocol.
- [10]MedlinePlus: when to use an emergency room · Source date: Source date is shown on the original page · Reviewed
General emergency signs and care settings, not individual triage.
Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed.
See a problem or outdated information? Tell us.